Latest Articles
Changes in the M1/M2 ratio due to andrographolide therapy for deep endometriosis: An experimental study using a BALB/C endometriosis model.
Andrographolide is a compound that serves as an anti-inflammatory agent. M2 macrophages promote the disease, while M1 macrophages inhibit endometriosis progression.
Published: June 30, 2025, midnight
LIN28B Promotes the Progression of Endometrial Cancer through Upregulating MYC and Correlates with Immune Microenvironment - Frontiers
LIN28B Promotes the Progression of Endometrial Cancer through Upregulating MYC and Correlates with Immune Microenvironment Frontiers
Published: June 26, 2025, 1:55 p.m.
ARNTL-mediated INO80-DHX15 axis reprograms the glycolytic metabolism and augments the progression of endometrial carcinoma - Nature
ARNTL-mediated INO80-DHX15 axis reprograms the glycolytic metabolism and augments the progression of endometrial carcinoma Nature
Published: June 20, 2025, 8:06 p.m.
EZH2 Promotes Endometriosis Progression through Estrogen Receptor and TNFα Expression - Frontiers
EZH2 Promotes Endometriosis Progression through Estrogen Receptor and TNFα Expression Frontiers
Published: June 9, 2025, 12:32 p.m.
NHE7 drives endometrial cancer progression by delaying senescence through cAMP/CREB/GRIN2B axis-mediated Ca²⁺ influx - Nature
NHE7 drives endometrial cancer progression by delaying senescence through cAMP/CREB/GRIN2B axis-mediated Ca²⁺ influx Nature
Published: June 5, 2025, 9:33 p.m.
Extracellular matrix stiffness in endometrial cancer: driving progression and modulating treatment sensitivity via the ROCK1/YAP1 axis - Nature
Extracellular matrix stiffness in endometrial cancer: driving progression and modulating treatment sensitivity via the ROCK1/YAP1 axis Nature
Published: May 15, 2025, 12:37 a.m.
Current Insights into Endometriosis: Hormonal Management, Clinical Outcomes, and Opportunities for Progress.
Endometriosis, a prevalent women's health condition, is associated with persistent pelvic pain and infertility. Despite ongoing research, its precise disease mechanism remains elusive, impeding the discovery of a definitive cure. …
Published: April 8, 2025, midnight
Adoptive transfer of regulatory T cells inhibits the progression of endometriosis-like lesions in regulatory T-cell-depleted mice.
Does the restoration of regulatory T cells (Tregs) suppress the progression of endometriosis?
Published: April 3, 2025, midnight
Optimizing Management Strategies for Advanced Endometrial Cancer Progression After IO-Chemo - OncLive
Optimizing Management Strategies for Advanced Endometrial Cancer Progression After IO-Chemo OncLive
Published: March 31, 2025, 2:14 p.m.
SIRT7 facilitates endometrial cancer progression by regulating PTEN stability in an estrogen-dependent manner - Nature.com
SIRT7 facilitates endometrial cancer progression by regulating PTEN stability in an estrogen-dependent manner Nature.com
Published: March 27, 2025, 6:35 a.m.
Link copied to clipboard!